Feedback / Questions
enibarcimab (HAM 8101) - Adrenomed
http://clinicaltrials.gov/ct2/show/NCT05156671
Jul 1, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next